Business Description
Oramed Pharmaceuticals is a New York-based drug development company focused on making it possible for patients to take insulin and other protein-based medicines as a pill rather than an injection. Its leading product, an oral insulin capsule called ORMD-0801, is currently in late-stage clinical trials for people living with diabetes. The company also holds licensing rights to develop oral vaccines targeting COVID-19 and related coronaviruses.
